Download Files:
Products Details
Product Description
– HBV-IN-39-d3 (Example 14) is a deuterated HBV-IN-39 (Example 13). HBV-IN-39 is an HBV inhibitor. HBV-IN-39-d3 has better oral bioavailability than HBV-IN-39[1].
Web ID
– HY-156703S
Shipping
– Room temperature
Molecular Formula
– C23H25D3FNO6
References
– [1]Yi Chen, et al. Therapeutic agents for the treatment of HBV infection. Patent CN110240596B.
CAS Number
– 2173356-23-3
Molecular Weight
– 436.49
SMILES
– FC1=C2C3=CC(OC([2H])([2H])[2H])=C(OCCCOC)C=C3C[C@H](N2C=C(C1=O)C(O)=O)C(C)(C)C
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– HBV
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
